Patents
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
02/2015
02/12/2015US20150044291 Methods for the treatment of endometriosis
02/12/2015US20150044206 Immunoglobulin formulation and method of preparation thereof
02/05/2015US20150038570 Compositions and products containing s-equol, and methods for their making
02/03/2015US8946290 Combination of selected opioids with muscarine antagonists for treating urinary incontinence
02/03/2015US8946179 Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
02/03/2015US8945921 Modulating the production of neurons and/or oligodendrocytes from white matter progenitor cells
01/2015
01/29/2015US20150031881 Pyrazolo pyrimidine derivatives and methods of use thereof
01/29/2015US20150031719 Topical Therapy for the Treatment of Migraines, Muscle Sprains, Muscle Spasms, Spasticity and Related Conditions
01/28/2015CN104311658A 新的受体核酸及多肽 The new receptor nucleic acids and peptides
01/28/2015CN102349914B 包含3,4-丙炔基全氢化嘌呤的药物组合物及其在阻滞神经元传递方面的应用 Comprising 3,4-propynyl perhydro purine pharmaceutical compositions and their application in terms of blocking neuronal transfer
01/27/2015US8940755 Therapeutic combinations and methods including IRM compounds
01/27/2015US8940535 Stem cell culture medium and method of using said medium and the cells
01/22/2015US20150023990 Alkoxy substituted imidazoquinolines
01/22/2015US20150023942 Compositions and methods for promoting neuronal outgrowth
01/21/2015EP2826484A1 IRS modulators
01/20/2015US8937156 Saposin C-DOPS: a novel anti-tumor agent
01/20/2015US8936810 Methods and apparatus for determining formulation orientation of multi-layered pharmaceutical dosage forms
01/20/2015US8936807 Use of the cathelicidin LL-37 and derivatives thereof for wound healing
01/15/2015US20150017179 Method of Treatment and Bioassay Involving Macrophage Migration Inhibitory Factor (MIF) as Cardiac-Derived Myocardial Depressant Factor
01/14/2015CN104274442A 癌症的治疗 Treatment of cancer
01/13/2015US8933041 System for treating and preventing breast cancer
01/13/2015US8932649 Methods for treating a neoplastic disease in a subject using inorganic selenium-containing compounds
01/08/2015US20150011563 Treating Sexual Desire Disorders with Flibanserin
01/08/2015US20150010946 Polynucleotides encoding zcytor17 ligand antibodies
01/08/2015US20150010558 Compositions and methods for treating coagulation related disorders
01/06/2015US8926985 Vaccine
01/06/2015CA2421998C Vaccine against streptococcus pneumoniae
01/01/2015US20150005374 Compounds and methods for delivery of prostacyclin analogs
12/2014
12/30/2014USRE45313 Exendin variant peptides
12/30/2014US8920824 Pretreatment or post exposure treatment for exposure to a toxic substance by pulmonary delivery (inhaler) of a bioscavenger
12/30/2014US8920781 Carrier particles for use in dry powder inhalers
12/25/2014US20140378512 Composition for improving cognition and memory
12/25/2014US20140378465 Method of treating diabetes
12/23/2014US8916174 HIV DNA vaccine regulated by a caev-derived promoter
12/18/2014US20140370104 Pharmaceutical formulation and method for treating acid caused gastrointestinal disorders
12/18/2014US20140369982 Prebiotic and preservative uses of oil emulsified probiotic encapsulations
12/16/2014US8911950 Methods and compositions for inhibiting the growth of hematopoietic malignant cells
12/16/2014US8911665 Antiseptic compositions, methods and systems
12/09/2014US8906884 Method of treating graft-rejection using dextran sulfate
12/09/2014US8906843 Functional fragrance precursor
12/09/2014US8906363 Fusion proteins for the treatment of CNS
12/04/2014US20140356342 Human beta-adrenergic receptor kinase polypeptide and methods
12/02/2014US8901303 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
12/02/2014US8901130 Low hygroscopic aripiprazole drug substance and processes for the preparation
12/02/2014US8901104 Use of dextran sulfate
12/02/2014US8901093 Custom vectors for treating and preventing pancreatic cancer
12/02/2014US8901068 Functional fragrance precursor
12/02/2014US8900636 Controlled release compositions
12/02/2014US8900577 Immunoglobulin formulation and method of preparation thereof
11/2014
11/25/2014US8895543 Vinca derivatives
11/25/2014US8895501 Eye-drop vaccine containing copolymer 1 for therapeutic immunization
11/25/2014US8895496 Functional fragrance precursor
11/25/2014US8895495 Functional fragrance precursor
11/20/2014US20140343006 HIV Replication Inhibiting Pyrimidines
11/20/2014US20140342943 Screening methods for cognitive enhancers
11/20/2014US20140341972 Method to induce neovascular formation and tissue regeneration
11/18/2014US8889681 Use and application of a pharmaceutical composition containing a mixture of natural-origin heterocyclical guanidine, for cosmetology, wound healing, focal dystonia and muscular spasm-related clinical pathologies
11/18/2014US8887715 Low dose pharmaceutical powders for inhalation
11/13/2014US20140336370 Oligomeric compounds and compositions for use in modulation of small non-coding rnas
11/13/2014US20140336356 Peptide agonists of glp-1 activity
11/11/2014US8883830 Topical therapy for the treatment of migraines, muscle sprains, muscle spasms, spasticity and related conditions
11/11/2014US8883750 Method of treating diabetes
11/06/2014US20140329882 Oligomeric compounds and compositions for use in modulation of small non-coding rnas
11/06/2014US20140329765 Methods and Compositions for the Treatment of Gastrointestinal Disorders
11/06/2014US20140328813 Combination Bacteriolytic Therapy for the Treatment of Tumors
11/06/2014US20140326759 Medicinal aerosols and methods of delivery thereof
11/04/2014US8877771 Treatment of solid tumors with rapamycin derivatives
11/04/2014US8877709 Reversible pegylated drugs
10/2014
10/30/2014US20140322325 Pharmaceutical compositions providing enhanced drug concentrations
10/30/2014US20140322282 Microcrystalline Cellulose Compositions
10/30/2014US20140322192 Proteoglycan degrading mutants for treatment of cns
10/28/2014US8871782 Alkoxy substituted imidazoquinolines
10/28/2014US8871763 Use and application of a pharmaceutical composition containing a mixture of natural-origin heterocyclical guanidine, for cosmetology, wound healing, focal dystonia and muscular spasm- related clinical pathologies
10/28/2014US8871269 Method for the preparation of controlled release formulations
10/28/2014US8871227 Process and formulation containing epothilones and analogs thereof
10/16/2014US20140309411 Therapeutic compositions
10/16/2014US20140309236 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
10/16/2014US20140308376 Cosmetic Compositions and Methods for Using Same to Improve the Aesthetic Appearance of Skin
10/14/2014US8859593 Composition for improving cognition and memory
10/14/2014US8859523 Crosslinked compounds and methods of making and using thereof
10/14/2014US8859521 Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
10/14/2014US8858918 Chewing gum and confectionery compositions with encapsulated stain removing agent compositions, and methods of making and using the same
10/09/2014US20140303200 Polymorphic Forms of Naltrexone
10/09/2014US20140302499 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors
10/07/2014US8853178 Antisense modulation of PTP1B expression
10/07/2014US8852650 Use of BBI/BBIC for treatment of muscular atrophy and degenerative muscle disease
10/02/2014US20140296258 Trisubstituted triazolopyrimidines for use in platelet aggregation inhibiton
10/02/2014US20140296163 Methods and Compositions for the Treatment of Gastrointestinal Disorders
10/02/2014US20140294763 Peptidomimetic protease inhibitors
09/2014
09/30/2014US8846082 Probiotic and preservative uses of oil-emulsified probiotic encapsulations
09/30/2014US8846075 Composition material for transmucosal delivery
09/30/2014US8846026 Composition comprising immunogenic microparticles
09/25/2014US20140288034 Compound capable of binding s1p receptor and pharmaceutical use thereof
09/25/2014US20140287494 Mesendoderm and mesoderm cell populations
09/25/2014US20140286941 Treatment of tnfalpha related disorders
09/25/2014US20140286940 Treatment of tnfalpha related disorders
09/25/2014US20140286939 Treatment of tnfalpha related disorders
09/25/2014US20140286878 Composition for inhalation
09/23/2014US8840892 Method of administering antibiotic therapy for treating intracellular infectious diseases
09/18/2014US20140271868 Treatment of achondroplasia with encapsulated cnp-secreting cells
1 2 3 4 5 6 7 8 9 10 11 ... 295